Director, HTA, Value & Evidence (HV&E), I&I / ...

The Director, Value & Evidence - Brepocitinib will support the strategic goals of the Inflammation & Immunology Business Unit by driving optimal launch and patient access for Brepocitinib through the generation, integration, and translation of robust value and evidence. This role directly impacts Pfizer's ability to achieve global access and reimbursement objectives by providing strategic leadership and execution of Health Technology Assessment, Value & Evidence (HV&E) activities that demonstrate the value of Brepocitinib across its lifecycle, including launch and post-launch phases. This role is part of a collaborative Brepocitinib HV&E team structure, working alongside existing team members to jointly deliver launch and lifecycle evidence. The Director will partner with the Brepocitinib HV&E team to develop and execute the global value and evidence generation strategy for Brepocitinib, including supporting oversight of evidence generation activities and dissemination of technical deliverables in close partnership with GASP, cross-functional and alliance teams. This position will function with a one

Created: 2026-04-20